{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T02:45:07Z","timestamp":1791341107802,"version":"4.3.1"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2017,4,20]],"date-time":"2017-04-20T00:00:00Z","timestamp":1492646400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2017,4,20]],"date-time":"2017-04-20T00:00:00Z","timestamp":1492646400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Gene Ther"],"published-print":{"date-parts":[[2017,5]]},"DOI":"10.1038\/gt.2017.20","type":"journal-article","created":{"date-parts":[[2017,3,27]],"date-time":"2017-03-27T10:42:33Z","timestamp":1490611353000},"page":"298-307","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":55,"title":["Detailed comparison of retroviral vectors and promoter configurations for stable and high transgene expression in human induced pluripotent stem cells"],"prefix":"10.1038","volume":"24","author":[{"given":"D","family":"Hoffmann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J W","family":"Schott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F K","family":"Geis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L","family":"Lange","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F-J","family":"M\u00fcller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D","family":"Lenz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D","family":"Zychlinski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D","family":"Steinemann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Morgan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"Moritz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Schambach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,4,20]]},"reference":[{"key":"BFgt201720_CR1","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1517\/14712598.2010.496775","volume":"10","author":"A Schambach","year":"2010","unstructured":"Schambach A, Cantz T, Baum C, Cathomen T . Generation and genetic modification of induced pluripotent stem cells. Expert Opin Biol Ther 2010; 10: 1089\u20131103.","journal-title":"Expert Opin Biol Ther"},{"key":"BFgt201720_CR2","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1146\/annurev-med-050311-163324","volume":"64","author":"AB Cherry","year":"2013","unstructured":"Cherry AB, Daley GQ . Reprogrammed cells for disease modeling and regenerative medicine. Annu Rev Med 2013; 64: 277\u2013290.","journal-title":"Annu Rev Med"},{"key":"BFgt201720_CR3","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1089\/hum.2005.16.1241","volume":"16","author":"J Ellis","year":"2005","unstructured":"Ellis J . Silencing and variegation of gammaretrovirus and lentivirus vectors. Hum Gene Ther 2005; 16: 1241\u20131246.","journal-title":"Hum Gene Ther"},{"key":"BFgt201720_CR4","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1038\/sj.gt.3302923","volume":"14","author":"HP Mok","year":"2007","unstructured":"Mok HP, Javed S, Lever A . Stable gene expression occurs from a minority of integrated HIV-1-based vectors: transcriptional silencing is present in the majority. Gene Ther 2007; 14: 741\u2013751.","journal-title":"Gene Ther"},{"key":"BFgt201720_CR5","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.1634\/stemcells.2007-1106","volume":"26","author":"S Minoguchi","year":"2008","unstructured":"Minoguchi S, Iba H . Instability of retroviral DNA methylation in embryonic stem cells. Stem Cells 2008; 26: 1166\u20131173.","journal-title":"Stem Cells"},{"key":"BFgt201720_CR6","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1038\/mt.2012.46","volume":"20","author":"F Herbst","year":"2012","unstructured":"Herbst F, Ball CR, Tuorto F, Nowrouzi A, Wang W, Zavidij O et al. Extensive methylation of promoter sequences silences lentiviral transgene expression during stem cell differentiation in vivo. Mol Ther 2012; 20: 1014\u20131021.","journal-title":"Mol Ther"},{"key":"BFgt201720_CR7","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.cell.2007.07.026","volume":"131","author":"D Wolf","year":"2007","unstructured":"Wolf D, Goff SP . TRIM28 mediates primer binding site-targeted silencing of murine leukemia virus in embryonic cells. Cell 2007; 131: 46\u201357.","journal-title":"Cell"},{"key":"BFgt201720_CR8","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.celrep.2013.06.003","volume":"4","author":"S Schlesinger","year":"2013","unstructured":"Schlesinger S, Lee AH, Wang GZ, Green L, Goff SP . Proviral silencing in embryonic cells is regulated by Yin Yang 1. Cell Rep 2013; 4: 50\u201358.","journal-title":"Cell Rep"},{"key":"BFgt201720_CR9","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1038\/nature07844","volume":"458","author":"D Wolf","year":"2009","unstructured":"Wolf D, Goff SP . Embryonic stem cells use ZFP809 to silence retroviral DNAs. Nature 2009; 458: 1201\u20131204.","journal-title":"Nature"},{"key":"BFgt201720_CR10","doi-asserted-by":"publisher","first-page":"9202","DOI":"10.1073\/pnas.87.23.9202","volume":"87","author":"M Grez","year":"1990","unstructured":"Grez M, Akgun E, Hilberg F, Ostertag W . Embryonic stem cell virus, a recombinant murine retrovirus with expression in embryonic stem cells. Proc Natl Acad Sci USA 1990; 87: 9202\u20139206.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFgt201720_CR11","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1006\/mthe.2000.0190","volume":"2","author":"A Ramezani","year":"2000","unstructured":"Ramezani A, Hawley TS, Hawley RG . Lentiviral vectors for enhanced gene expression in human hematopoietic cells. Mol Ther 2000; 2: 458\u2013469.","journal-title":"Mol Ther"},{"key":"BFgt201720_CR12","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.ymthe.2006.04.005","volume":"14","author":"A Ramezani","year":"2006","unstructured":"Ramezani A, Hawley TS, Hawley RG . Stable gammaretroviral vector expression during embryonic stem cell-derived in vitro hematopoietic development. Mol Ther 2006; 14: 245\u2013254.","journal-title":"Mol Ther"},{"key":"BFgt201720_CR13","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1089\/hum.2013.062","volume":"24","author":"MN Antoniou","year":"2013","unstructured":"Antoniou MN, Skipper KA, Anakok O . Optimizing retroviral gene expression for effective therapies. Hum Gene Ther 2013; 24: 363\u2013374.","journal-title":"Hum Gene Ther"},{"key":"BFgt201720_CR14","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1089\/hum.2010.233","volume":"22","author":"DW Emery","year":"2011","unstructured":"Emery DW . The use of chromatin insulators to improve the expression and safety of integrating gene transfer vectors. Hum Gene Ther 2011; 22: 761\u2013774.","journal-title":"Hum Gene Ther"},{"key":"BFgt201720_CR15","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/S0888-7543(03)00107-1","volume":"82","author":"M Antoniou","year":"2003","unstructured":"Antoniou M, Harland L, Mustoe T, Williams S, Holdstock J, Yague E et al. Transgenes encompassing dual-promoter CpG islands from the human TBP and HNRPA2B1 loci are resistant to heterochromatin-mediated silencing. Genomics 2003; 82: 269\u2013279.","journal-title":"Genomics"},{"key":"BFgt201720_CR16","doi-asserted-by":"publisher","first-page":"1527","DOI":"10.1038\/mt.2009.89","volume":"17","author":"F Urbinati","year":"2009","unstructured":"Urbinati F, Arumugam P, Higashimoto T, Perumbeti A, Mitts K, Xia P et al. Mechanism of reduction in titers from lentivirus vectors carrying large inserts in the 3'LTR. Mol Ther 2009; 17: 1527\u20131536.","journal-title":"Mol Ther"},{"key":"BFgt201720_CR17","doi-asserted-by":"publisher","first-page":"3445","DOI":"10.1182\/blood-2004-04-1427","volume":"104","author":"G Puthenveetil","year":"2004","unstructured":"Puthenveetil G, Scholes J, Carbonell D, Qureshi N, Xia P, Zeng L et al. Successful correction of the human beta-thalassemia major phenotype using a lentiviral vector. Blood 2004; 104: 3445\u20133453.","journal-title":"Blood"},{"key":"BFgt201720_CR18","doi-asserted-by":"publisher","first-page":"e48421","DOI":"10.1371\/journal.pone.0048421","volume":"7","author":"N Sharma","year":"2012","unstructured":"Sharma N, Hollensen AK, Bak RO, Staunstrup NH, Schroder LD, Mikkelsen JG . The impact of cHS4 insulators on DNA transposon vector mobilization and silencing in retinal pigment epithelium cells. PloS One 2012; 7: e48421.","journal-title":"PloS One"},{"key":"BFgt201720_CR19","doi-asserted-by":"publisher","first-page":"1448","DOI":"10.1182\/blood-2006-12-060814","volume":"110","author":"F Zhang","year":"2007","unstructured":"Zhang F, Thornhill SI, Howe SJ, Ulaganathan M, Schambach A, Sinclair J et al. Lentiviral vectors containing an enhancer-less ubiquitously acting chromatin opening element (UCOE) provide highly reproducible and stable transgene expression in hematopoietic cells. Blood 2007; 110: 1448\u20131457.","journal-title":"Blood"},{"key":"BFgt201720_CR20","doi-asserted-by":"publisher","first-page":"1640","DOI":"10.1038\/mt.2010.132","volume":"18","author":"F Zhang","year":"2010","unstructured":"Zhang F, Frost AR, Blundell MP, Bales O, Antoniou MN, Thrasher AJ . A ubiquitous chromatin opening element (UCOE) confers resistance to DNA methylation-mediated silencing of lentiviral vectors. Mol Ther 2010; 18: 1640\u20131649.","journal-title":"Mol Ther"},{"key":"BFgt201720_CR21","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1002\/stem.1316","volume":"31","author":"N Pfaff","year":"2013","unstructured":"Pfaff N, Lachmann N, Ackermann M, Kohlscheen S, Brendel C, Maetzig T et al. A ubiquitous chromatin opening element prevents transgene silencing in pluripotent stem cells and their differentiated progeny. Stem Cells 2013; 31: 488\u2013499.","journal-title":"Stem Cells"},{"key":"BFgt201720_CR22","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.1016\/j.biomaterials.2013.11.024","volume":"35","author":"M Ackermann","year":"2014","unstructured":"Ackermann M, Lachmann N, Hartung S, Eggenschwiler R, Pfaff N, Happle C et al. Promoter and lineage independent anti-silencing activity of the A2 ubiquitous chromatin opening element for optimized human pluripotent stem cell-based gene therapy. Biomaterials 2014; 35: 1531\u20131542.","journal-title":"Biomaterials"},{"key":"BFgt201720_CR23","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1093\/nar\/gkv019","volume":"43","author":"U Muller-Kuller","year":"2015","unstructured":"Muller-Kuller U, Ackermann M, Kolodziej S, Brendel C, Fritsch J, Lachmann N et al. A minimal ubiquitous chromatin opening element (UCOE) effectively prevents silencing of juxtaposed heterologous promoters by epigenetic remodeling in multipotent and pluripotent stem cells. Nucleic Acids Res 2015; 43: 1577\u20131592.","journal-title":"Nucleic Acids Res"},{"key":"BFgt201720_CR24","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1038\/mt.2010.314","volume":"19","author":"E Warlich","year":"2011","unstructured":"Warlich E, Kuehle J, Cantz T, Brugman MH, Maetzig T, Galla M et al. Lentiviral vector design and imaging approaches to visualize the early stages of cellular reprogramming. Mol Ther 2011; 19: 782\u2013789.","journal-title":"Mol Ther"},{"key":"BFgt201720_CR25","doi-asserted-by":"publisher","first-page":"7805","DOI":"10.1073\/pnas.0914517107","volume":"107","author":"C Voelkel","year":"2010","unstructured":"Voelkel C, Galla M, Maetzig T, Warlich E, Kuehle J, Zychlinski D et al. Protein transduction from retroviral Gag precursors. Proc Natl Acad USA 2010; 107: 7805\u20137810.","journal-title":"Proc Natl Acad USA"},{"key":"BFgt201720_CR26","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1038\/mt.2012.249","volume":"21","author":"KB Kaufmann","year":"2013","unstructured":"Kaufmann KB, Brendel C, Suerth JD, Mueller-Kuller U, Chen-Wichmann L, Schwable J et al. Alpharetroviral vector-mediated gene therapy for X-CGD: functional correction and lack of aberrant splicing. Mol Ther 2013; 21: 648\u2013661.","journal-title":"Mol Ther"},{"key":"BFgt201720_CR27","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1007\/s00109-015-1327-6","volume":"94","author":"JD Suerth","year":"2016","unstructured":"Suerth JD, Morgan MA, Kloess S, Heckl D, Neudorfl C, Falk CS et al. Efficient generation of gene-modified human natural killer cells via alpharetroviral vectors. J Mol Med 2016; 94: 83\u201393.","journal-title":"J Mol Med"},{"key":"BFgt201720_CR28","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.biomaterials.2016.04.019","volume":"97","author":"V Labenski","year":"2016","unstructured":"Labenski V, Suerth JD, Barczak E, Heckl D, Levy C, Bernadin O et al. Alpharetroviral self-inactivating vectors produced by a superinfection-resistant stable packaging cell line allow genetic modification of primary human T lymphocytes. Biomaterials 2016; 97: 97\u2013109.","journal-title":"Biomaterials"},{"key":"BFgt201720_CR29","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1038\/mt.2011.309","volume":"20","author":"JD Suerth","year":"2012","unstructured":"Suerth JD, Maetzig T, Brugman MH, Heinz N, Appelt JU, Kaufmann KB et al. Alpharetroviral self-inactivating vectors: long-term transgene expression in murine hematopoietic cells and low genotoxicity. Mol Ther 2012; 20: 1022\u20131032.","journal-title":"Mol Ther"},{"key":"BFgt201720_CR30","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1056\/NEJMoa1404588","volume":"371","author":"S Hacein-Bey-Abina","year":"2014","unstructured":"Hacein-Bey-Abina S, Pai SY, Gaspar HB, Armant M, Berry CC, Blanche S et al. A modified gamma-retrovirus vector for X-linked severe combined immunodeficiency. N Engl J Med 2014; 371: 1407\u20131417.","journal-title":"N Engl J Med"},{"key":"BFgt201720_CR31","doi-asserted-by":"publisher","first-page":"1233151","DOI":"10.1126\/science.1233151","volume":"341","author":"A Aiuti","year":"2013","unstructured":"Aiuti A, Biasco L, Scaramuzza S, Ferrua F, Cicalese MP, Baricordi C et al. Lentiviral hematopoietic stem cell gene therapy in patients with Wiskott-Aldrich syndrome. Science 2013; 341: 1233151.","journal-title":"Science"},{"key":"BFgt201720_CR32","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1038\/nature15818","volume":"526","author":"L Naldini","year":"2015","unstructured":"Naldini L . Gene therapy returns to centre stage. Nature 2015; 526: 351\u2013360.","journal-title":"Nature"},{"key":"BFgt201720_CR33","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1038\/nature08129","volume":"460","author":"A Raya","year":"2009","unstructured":"Raya A, Rodriguez-Piza I, Guenechea G, Vassena R, Navarro S, Barrero MJ et al. Disease-corrected haematopoietic progenitors from Fanconi anaemia induced pluripotent stem cells. Nature 2009; 460: 53\u201359.","journal-title":"Nature"},{"key":"BFgt201720_CR34","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1164\/rccm.201306-1012OC","volume":"189","author":"N Lachmann","year":"2014","unstructured":"Lachmann N, Happle C, Ackermann M, Luttge D, Wetzke M, Merkert S et al. Gene correction of human induced pluripotent stem cells repairs the cellular phenotype in pulmonary alveolar proteinosis. Am J Respir Crit Care Med 2014; 189: 167\u2013182.","journal-title":"Am J Respir Crit Care Med"},{"key":"BFgt201720_CR35","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1038\/nbt.1717","volume":"29","author":"EP Papapetrou","year":"2010","unstructured":"Papapetrou EP, Lee G, Malani N, Setty M, Riviere I, Tirunagari LM et al. Genomic safe harbors permit high beta-globin transgene expression in thalassemia induced pluripotent stem cells. Nat Biotechnol 2010; 29: 73\u201378.","journal-title":"Nat Biotechnol"},{"key":"BFgt201720_CR36","doi-asserted-by":"publisher","first-page":"19","DOI":"10.3324\/haematol.2013.083873","volume":"99","author":"T Morishima","year":"2014","unstructured":"Morishima T, Watanabe K, Niwa A, Hirai H, Saida S, Tanaka T et al. Genetic correction of HAX1 in induced pluripotent stem cells from a patient with severe congenital neutropenia improves defective granulopoiesis. Haematologica 2014; 99: 19\u201327.","journal-title":"Haematologica"},{"key":"BFgt201720_CR37","doi-asserted-by":"publisher","first-page":"7306","DOI":"10.1073\/pnas.1214441110","volume":"110","author":"D Finkelshtein","year":"2013","unstructured":"Finkelshtein D, Werman A, Novick D, Barak S, Rubinstein M . LDL receptor and its family members serve as the cellular receptors for vesicular stomatitis virus. Proc Natl Acad Sci USA 2013; 110: 7306\u20137311.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFgt201720_CR38","doi-asserted-by":"publisher","first-page":"1422","DOI":"10.1182\/blood-2013-11-540641","volume":"123","author":"F Amirache","year":"2014","unstructured":"Amirache F, Levy C, Costa C, Mangeot PE, Torbett BE, Wang CX et al. Mystery solved: VSV-G-LVs do not allow efficient gene transfer into unstimulated T cells, B cells, and HSCs because they lack the LDL receptor. Blood 2014; 123: 1422\u20131424.","journal-title":"Blood"},{"key":"BFgt201720_CR39","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1073\/pnas.96.5.2129","volume":"96","author":"JE Rasko","year":"1999","unstructured":"Rasko JE, Battini JL, Gottschalk RJ, Mazo I, Miller AD . The RD114\/simian type D retrovirus receptor is a neutral amino acid transporter. Proc Natl Acad Sci USA 1999; 96: 2129\u20132134.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFgt201720_CR40","doi-asserted-by":"publisher","first-page":"e12413","DOI":"10.1371\/journal.pone.0012413","volume":"5","author":"K Norrman","year":"2010","unstructured":"Norrman K, Fischer Y, Bonnamy B, Wolfhagen Sand F, Ravassard P, Semb H . Quantitative comparison of constitutive promoters in human ES cells. PloS One 2010; 5: e12413.","journal-title":"PloS One"},{"key":"BFgt201720_CR41","doi-asserted-by":"publisher","first-page":"1536","DOI":"10.1038\/mt.2013.131","volume":"21","author":"S Rival-Gervier","year":"2013","unstructured":"Rival-Gervier S, Lo MY, Khattak S, Pasceri P, Lorincz MC, Ellis J . Kinetics and epigenetics of retroviral silencing in mouse embryonic stem cells defined by deletion of the D4Z4 element. Mol Ther 2013; 21: 1536\u20131550.","journal-title":"Mol Ther"},{"key":"BFgt201720_CR42","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1038\/mt.2016.38","volume":"24","author":"EP Papapetrou","year":"2016","unstructured":"Papapetrou EP, Schambach A . Gene insertion into genomic safe harbors for human gene therapy. Mol Ther 2016; 24: 678\u2013684.","journal-title":"Mol Ther"},{"key":"BFgt201720_CR43","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1016\/j.stemcr.2015.09.004","volume":"5","author":"L Ordovas","year":"2015","unstructured":"Ordovas L, Boon R, Pistoni M, Chen Y, Wolfs E, Guo W et al. Efficient recombinase-mediated cassette exchange in hPSCs to study the hepatocyte lineage reveals AAVS1 locus-mediated transgene inhibition. Stem Cell Rep 2015; 5: 918\u2013931.","journal-title":"Stem Cell Rep"},{"key":"BFgt201720_CR44","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1038\/mt.2014.4","volume":"22","author":"J Kuehle","year":"2014","unstructured":"Kuehle J, Turan S, Cantz T, Hoffmann D, Suerth JD, Maetzig T et al. Modified lentiviral LTRs allow Flp recombinase-mediated cassette exchange and in vivo tracing of \"Factor-free\" induced pluripotent stem cells. Mol Ther 2014; 22: 919\u2013928.","journal-title":"Mol Ther"},{"key":"BFgt201720_CR45","doi-asserted-by":"publisher","first-page":"6626","DOI":"10.1128\/JVI.00182-10","volume":"84","author":"JD Suerth","year":"2010","unstructured":"Suerth JD, Maetzig T, Galla M, Baum C, Schambach A . Self-inactivating alpharetroviral vectors with a split-packaging design. J Virol 2010; 84: 6626\u20136635.","journal-title":"J Virol"},{"key":"BFgt201720_CR46","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/j.ymthe.2005.08.012","volume":"13","author":"A Schambach","year":"2006","unstructured":"Schambach A, Bohne J, Chandra S, Will E, Margison GP, Williams DA et al. Equal potency of gammaretroviral and lentiviral SIN vectors for expression of O6-methylguanine-DNA methyltransferase in hematopoietic cells. Mol Ther 2006; 13: 391\u2013400.","journal-title":"Mol Ther"},{"key":"BFgt201720_CR47","doi-asserted-by":"publisher","first-page":"1524","DOI":"10.1038\/sj.gt.3302807","volume":"13","author":"A Schambach","year":"2006","unstructured":"Schambach A, Mueller D, Galla M, Verstegen MM, Wagemaker G, Loew R et al. Overcoming promoter competition in packaging cells improves production of self-inactivating retroviral vectors. Gene Ther 2006; 13: 1524\u20131533.","journal-title":"Gene Ther"},{"key":"BFgt201720_CR48","doi-asserted-by":"crossref","first-page":"8463","DOI":"10.1128\/JVI.72.11.8463-8471.1998","volume":"72","author":"T Dull","year":"1998","unstructured":"Dull T, Zufferey R, Kelly M, Mandel RJ, Nguyen M, Trono D et al. A third-generation lentivirus vector with a conditional packaging system. J Virol 1998; 72: 8463\u20138471.","journal-title":"J Virol"},{"key":"BFgt201720_CR49","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1038\/gt.2014.69","volume":"21","author":"JW Schott","year":"2014","unstructured":"Schott JW, Hoffmann D, Maetzig T, Muller FJ, Steinemann D, Zychlinski D et al. Improved retroviral episome transfer of transcription factors enables sustained cell fate modification. Gene Ther 2014; 21: 938\u2013949.","journal-title":"Gene Ther"},{"key":"BFgt201720_CR50","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/S0091-679X(08)60600-7","volume":"43","author":"JK Yee","year":"1994","unstructured":"Yee JK, Friedmann T, Burns JC . Generation of high-titer pseudotyped retroviral vectors with very broad host range. Methods Cell Biol 1994; 43 : 99\u2013112.","journal-title":"Methods Cell Biol"},{"key":"BFgt201720_CR51","doi-asserted-by":"publisher","first-page":"6349","DOI":"10.1073\/pnas.81.20.6349","volume":"81","author":"RD Cone","year":"1984","unstructured":"Cone RD, Mulligan RC . High-efficiency gene transfer into mammalian cells: generation of helper-free recombinant retrovirus with broad mammalian host range. Proc Natl Acad Sci USA 1984; 81: 6349\u20136353.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFgt201720_CR52","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1182\/blood-2001-11-0042","volume":"100","author":"V Sandrin","year":"2002","unstructured":"Sandrin V, Boson B, Salmon P, Gay W, Negre D, Le Grand R et al. Lentiviral vectors pseudotyped with a modified RD114 envelope glycoprotein show increased stability in sera and augmented transduction of primary lymphocytes and CD34+ cells derived from human and nonhuman primates. Blood 2002; 100: 823\u2013832.","journal-title":"Blood"},{"key":"BFgt201720_CR53","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1161\/ATVBAHA.113.302598","volume":"34","author":"VV Orlova","year":"2014","unstructured":"Orlova VV, Drabsch Y, Freund C, Petrus-Reurer S, van den Hil FE, Muenthaisong S et al. Functionality of endothelial cells and pericytes from human pluripotent stem cells demonstrated in cultured vascular plexus and zebrafish xenografts. Arterioscler Thromb Vasc Biol 2014; 34: 177\u2013186.","journal-title":"Arterioscler Thromb Vasc Biol"}],"container-title":["Gene Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/gt201720.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/gt201720","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/doifinder\/10.1038\/gt.2017.20","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/www.nature.com\/articles\/gt201720.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,26]],"date-time":"2022-07-26T18:46:07Z","timestamp":1658861167000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/gt201720"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4,20]]},"references-count":53,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2017,5]]}},"alternative-id":["BFgt201720"],"URL":"https:\/\/doi.org\/10.1038\/gt.2017.20","relation":{},"ISSN":["0969-7128","1476-5462"],"issn-type":[{"value":"0969-7128","type":"print"},{"value":"1476-5462","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,4,20]]},"assertion":[{"value":"5 October 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 January 2017","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 March 2017","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 April 2017","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}